Skip to content
healthcare.dev

TICAGRELOR

NDC 53401-028, TICAGRELOR, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
53401-028
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208596
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53401-028 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TICAGRELOR90 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]

Package NDCNDC-11Package
53401-028-42534010028421800 TABLET in 1 BOTTLE (53401-028-42)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5955a5f5-fbc7-8f67-e063-6394a90ada36

Use it

Look up 53401-028 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53401-028 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53401-028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.